Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TSPAN11 antisense RNA 1 (TSPAN11-AS1) is the putative antisense RNA transcript associated with the TSPAN11 gene. There is currently no scientific evidence supporting its role as a protein, receptor, enzyme, transporter, or druggable biological target. Unlike the well-studied tetraspanin family members (such as Tetraspanin 1/TSPAN1), which regulate cell adhesion, migration, proliferation, and are implicated in cancer progression[2][3][4], TSPAN11-AS1 lacks validated biological function or disease relevance. It is not recognized in major biomedical databases or literature as a therapeutic target, biomarker, or clinical entity. Given the lack of credible data, this may be a misidentified, misspelled, or incorrectly annotated target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TSPAN11 antisense RNA 1 (TSPAN11-AS1).